These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1839788)

  • 1. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of nitecapone.
    Slomiany BL; Piotrowski J; Rajiah G; Slomiany A
    Gen Pharmacol; 1991; 22(6):1063-9. PubMed ID: 1839788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide.
    Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A; Slomiany BL
    Gen Pharmacol; 1993 Nov; 24(6):1467-72. PubMed ID: 8112522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of ebrotidine.
    Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 Jun; 27(1):131-8. PubMed ID: 1385705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide: effect of sucralfate.
    Piotrowski J; Yamaki K; Slomiany A; Slomiany BL
    Am J Gastroenterol; 1991 Dec; 86(12):1756-60. PubMed ID: 1835819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Sengupta S; Slomiany A
    Biochem Biophys Res Commun; 1991 Mar; 175(3):963-70. PubMed ID: 1827258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Slomiany A; Piotrowski J; Slomiany BL
    Scand J Gastroenterol Suppl; 1995; 210():77-81. PubMed ID: 8578214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
    Piotrowski J; Skrodzka D; Slomiany A; Slomiany BL
    Gen Pharmacol; 1997 May; 28(5):705-8. PubMed ID: 9184806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosulfatase activity of Helicobacter pylori towards gastric sulfomucin: effect of nitecapone.
    Slomiany BL; Murty VL; Piotrowski J; Morita M; Slomiany A
    J Physiol Pharmacol; 1993 Mar; 44(1):7-16. PubMed ID: 8518427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide: effect of sulglycotide.
    Piotrowski J; Majka J; Murty VL; Czajkowski A; Slomiany A; Slomiany BL
    Gen Pharmacol; 1994 Sep; 25(5):969-76. PubMed ID: 7835646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Helicobacter pylori glycosulfatase activity toward gastric sulfomucin by nitecapone.
    Murty VL; Piotrowski J; Morita M; Slomiany A; Slomiany BL
    Biochem Int; 1992 May; 26(6):1091-9. PubMed ID: 1632804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1997 Jul; 42(3):545-51. PubMed ID: 9247712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine.
    Slomiany BL; Piotrowski J; Murty VL; Slomiany A
    Gen Pharmacol; 1995 Nov; 26(7):1553-8. PubMed ID: 8690245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitecapone effect on the synthesis and secretion of gastric sulfomucin.
    Slomiany BL; Liau YH; Lopez RA; Slomiany A
    Gen Pharmacol; 1993 Jan; 24(1):69-73. PubMed ID: 8387047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bismuth and nitecapone on acetaldehyde production by Helicobacter pylori.
    Salmela KS; Roine RP; Höök-Nikanne J; Kosunen TU; Salaspuro M
    Scand J Gastroenterol; 1994 Jun; 29(6):528-31. PubMed ID: 8079111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide.
    Piotrowski J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1993 Dec; 31(6):1051-8. PubMed ID: 7514919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide a virulence factor of Helicobacter pylori: effect of antiulcer agents.
    Piotrowski J
    J Physiol Pharmacol; 1998 Mar; 49(1):3-24. PubMed ID: 9594407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of sucralfate on gastric mucosal inflammatory responses induced by Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1998 Sep; 33(9):916-22. PubMed ID: 9759945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori lipopolysaccharide inhibition of gastric mucosal somatostatin receptor.
    Piotrowski J; Majka J; Slomiany A; Slomiany BL
    Biochem Mol Biol Int; 1995 Jul; 36(3):491-8. PubMed ID: 7549946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against alcohol-induced gastric mucosal injury by nitecapone.
    Slomiany BL; Piotrowski J; Ismail A; Rajiyah G; Tamura S; Bielanski W; Slomiany A
    Gen Pharmacol; 1991; 22(6):1055-62. PubMed ID: 1810804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ebrotidine on gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide.
    Slomiany BL; Piotrowski J; Slomiany A
    J Physiol Pharmacol; 1999 Sep; 50(3):391-404. PubMed ID: 10574469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.